Britain approves Merck's COVID-19 pill in world first

13 Sept 20:56 Key points summarised by AI

Britain became the first country globally to approve Merck's oral antiviral COVID-19 pill, molnupiravir, a significant step in fighting the pandemic.
The drug, to be branded Lagevrio, is recommended for use within five days of symptom onset and has shown to halve the chances of death or hospitalization for high-risk individuals.
The UK has secured 480,000 courses, with Merck projecting to produce 10 million courses by year-end and at least 20 million in 2022.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.